Overview  >  Investor Relations  >  News & Events  >  Event Details

PFIZER ANALYST AND INVESTOR CALL TO DISCUSS DATA FROM AN ONGOING PHASE 1/2 STUDY OF MRNA-BASED VACCINE CANDIDATE AGAINST SARS-COV-2

07/01/2020 2:00 PM ET